{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T07:48:24Z","timestamp":1787384904241,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the One Hundred Talents Project of Putuo Hospital, Shanghai University of Traditional Chinese Medicine","award":["2022-RCQH-03"],"award-info":[{"award-number":["2022-RCQH-03"]}]},{"name":"the Science Technology Innovation Project of Putuo District Health System","award":["ptkwws202307"],"award-info":[{"award-number":["ptkwws202307"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03283-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:29:30Z","timestamp":1762252170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ursolic acid suppresses gastric cancer by targeting the miR-27a-3p\/Wnt\/\u03b2-catenin signaling axis"],"prefix":"10.1186","volume":"30","author":[{"given":"Fenfen","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"2","key":"3283_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.41.2.142","volume":"41","author":"SM Everett","year":"1997","unstructured":"Everett SM, Axon AT. Early gastric cancer in Europe. Gut. 1997;41(2):142\u201350. https:\/\/doi.org\/10.1136\/gut.41.2.142.","journal-title":"Gut"},{"key":"3283_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(13)70133-5","volume":"14","author":"T Fujita","year":"2013","unstructured":"Fujita T. Targeted therapy for gastric cancer. Lancet Oncol. 2013;14:440\u20132. https:\/\/doi.org\/10.1016\/S1470-2045(13)70133-5.","journal-title":"Lancet Oncol"},{"key":"3283_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30369-3","volume":"19","author":"A Patel","year":"2018","unstructured":"Patel A, Gupta VG. Adjuvant therapy in resectable gastric cancer-the CRITICS trial. Lancet Oncol. 2018;19:e328. https:\/\/doi.org\/10.1016\/S1470-2045(18)30369-3.","journal-title":"Lancet Oncol"},{"key":"3283_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Signal Transduct Target Ther"},{"key":"3283_CR5","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3748\/wjg.v28.i26.3027","volume":"28","author":"MB Novoa D\u00edaz","year":"2022","unstructured":"Novoa D\u00edaz MB, Mart\u00edn MJ, Gentili C. Tumor microenvironment involvement in colorectal cancer progression via Wnt\/\u03b2-catenin pathway: providing understanding of the complex mechanisms of chemoresistance. World J Gastroenterol. 2022;28:3027\u201346. https:\/\/doi.org\/10.3748\/wjg.v28.i26.3027.","journal-title":"World J Gastroenterol"},{"key":"3283_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108179","volume":"238","author":"DJ Flanagan","year":"2022","unstructured":"Flanagan DJ, Woodcock SA, Phillips C, Eagle C, Sansom OJ. Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition. Pharmacol Ther. 2022;238:108179. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108179.","journal-title":"Pharmacol Ther"},{"key":"3283_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000676","volume":"5","author":"CH Ooi","year":"2009","unstructured":"Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 2009;5:e1000676. https:\/\/doi.org\/10.1371\/journal.pgen.1000676.","journal-title":"PLoS Genet"},{"key":"3283_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1021\/acs.jnatprod.2c00224","volume":"85","author":"WS Byun","year":"2022","unstructured":"Byun WS, Bae ES, Kim WK, Lee SK. Antitumor activity of Rutaecarpine in human colorectal cancer cells by suppression of Wnt\/\u03b2-catenin signaling. J Nat Prod. 2022;85:1407\u201318. https:\/\/doi.org\/10.1021\/acs.jnatprod.2c00224.","journal-title":"J Nat Prod"},{"key":"3283_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.drudis.2021.11.014","volume":"27","author":"A Morris","year":"2022","unstructured":"Morris A, Pagare PP, Li J, Zhang Y. Drug discovery efforts toward inhibitors of canonical Wnt\/\u03b2-catenin signaling pathway in the treatment of cancer: a composition-of-matter review (2010\u20132020). Drug Discov Today. 2022;27:1115\u201327. https:\/\/doi.org\/10.1016\/j.drudis.2021.11.014.","journal-title":"Drug Discov Today"},{"key":"3283_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.636566","volume":"8","author":"GD Zheng","year":"2021","unstructured":"Zheng GD, Xu ZY, Hu C, Lv H, Xie HX, Huang T, et al. Exosomal miR-590-5p in serum as a biomarker for the diagnosis and prognosis of gastric cancer. Front Mol Biosci. 2021;8:636566. https:\/\/doi.org\/10.3389\/fmolb.2021.636566.","journal-title":"Front Mol Biosci"},{"key":"3283_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10147-019-01532-9","volume":"25","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang J, et al. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Int J Clin Oncol. 2020;25:89\u201399. https:\/\/doi.org\/10.1007\/s10147-019-01532-9.","journal-title":"Int J Clin Oncol"},{"key":"3283_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.23501","volume":"123","author":"L Xia","year":"2008","unstructured":"Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008;123:372\u20139. https:\/\/doi.org\/10.1002\/ijc.23501.","journal-title":"Int J Cancer"},{"key":"3283_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051702","volume":"7","author":"W Tang","year":"2012","unstructured":"Tang W, Zhu J, Su S, Wu W, Liu Q, Su F, et al. Mir-27 as a prognostic marker for breast cancer progression and patient survival. PLoS ONE. 2012;7:e51702. https:\/\/doi.org\/10.1371\/journal.pone.0051702.","journal-title":"PLoS ONE"},{"key":"3283_CR14","doi-asserted-by":"publisher","first-page":"51943","DOI":"10.18632\/oncotarget.10460","volume":"7","author":"L Zhou","year":"2016","unstructured":"Zhou L, Liang X, Zhang L, Yang L, Nagao N, Wu H, et al. Mir-27a-3p functions as an oncogene in gastric cancer by targeting BTG2. Oncotarget. 2016;7:51943\u201354. https:\/\/doi.org\/10.18632\/oncotarget.10460.","journal-title":"Oncotarget"},{"key":"3283_CR15","doi-asserted-by":"publisher","first-page":"82991","DOI":"10.18632\/oncotarget.19635","volume":"8","author":"J Liang","year":"2017","unstructured":"Liang J, Tang J, Shi H, Li H, Zhen T, Duan J, et al. Mir-27a-3p targeting RXR\u03b1 promotes colorectal cancer progression by activating Wnt\/\u03b2-catenin pathway. Oncotarget. 2017;8:82991\u20133008. https:\/\/doi.org\/10.18632\/oncotarget.19635.","journal-title":"Oncotarget"},{"key":"3283_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","volume":"49","author":"J Liu","year":"1995","unstructured":"Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995;49:57\u201368. https:\/\/doi.org\/10.1016\/0378-8741(95)90032-2.","journal-title":"J Ethnopharmacol"},{"key":"3283_CR17","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-11-2805","volume":"18","author":"S Prasad","year":"2012","unstructured":"Prasad S, Yadav VR, Sung B, Reuter S, Kannappan R, Deorukhkar A, et al. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 2012;18:4942\u201353. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2805.","journal-title":"Clin Cancer Res"},{"key":"3283_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/ijo.2017.4035","volume":"51","author":"T Liu","year":"2017","unstructured":"Liu T, Ma H, Shi W, Duan J, Wang Y, Zhang C, et al. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. Int J Oncol. 2017;51:555\u201362. https:\/\/doi.org\/10.3892\/ijo.2017.4035.","journal-title":"Int J Oncol"},{"issue":"9","key":"3283_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1631\/jzus.B1600266","volume":"17","author":"JZ Shan","year":"2016","unstructured":"Shan JZ, Xuan YY, Zhang Q, Huang JJ. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1\u03b1. J Zhejiang Univ Sci B. 2016;17(9):672\u201382. https:\/\/doi.org\/10.1631\/jzus.B1600266.","journal-title":"J Zhejiang Univ Sci B"},{"key":"3283_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jnutbio.2015.09.014","volume":"33","author":"H Kim","year":"2016","unstructured":"Kim H, Ramirez CN, Su Z-Y, Kong A-NT. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells. J Nutr Biochem. 2016;33:54\u201362. https:\/\/doi.org\/10.1016\/j.jnutbio.2015.09.014.","journal-title":"J Nutr Biochem"},{"key":"3283_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/neuonc\/noae176","volume":"27","author":"KH Ho","year":"2025","unstructured":"Ho KH, Trapp M, Guida C, Ivanova EL, De Jaime-Soguero A, Jabali A, et al. Activation of Wnt\/\u03b2-catenin signaling is critical for the tumorigenesis of choroid plexus. Neuro Oncol. 2025;27:106\u201322. https:\/\/doi.org\/10.1093\/neuonc\/noae176.","journal-title":"Neuro Oncol"},{"key":"3283_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100586","volume":"37","author":"T Kervarrec","year":"2024","unstructured":"Kervarrec T, Cheok Lei K, Sohier P, Macagno N, Jullie M-L, Frouin E, et al. Wnt\/\u03b2-catenin-activated nonpilomatrical carcinoma of the skin: a case series. Mod Pathol. 2024;37:100586. https:\/\/doi.org\/10.1016\/j.modpat.2024.100586.","journal-title":"Mod Pathol"},{"key":"3283_CR23","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.3390\/cancers16162814","volume":"16","author":"M Berm\u00fadez","year":"2024","unstructured":"Berm\u00fadez M, Mart\u00ednez-Barajas MG, Bueno-Urquiza LJ, L\u00f3pez-Guti\u00e9rrez JA, Villegas-Mercado CE, L\u00f3pez-Camarillo C. Role of microrna-204 in regulating the hallmarks of breast cancer: an update. Cancers (Basel). 2024;16:2814. https:\/\/doi.org\/10.3390\/cancers16162814.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"3283_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-024-07004-x","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen XQ, Jia YX, Ma J, Xu D, Xiang ZL. Circ-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p. Cell Death Dis. 2024;15(8):630. https:\/\/doi.org\/10.1038\/s41419-024-07004-x.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3283_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2021.12856","volume":"22","author":"Y Liang","year":"2021","unstructured":"Liang Y, Zhao Y, Li L, Wei H, Huang T, Zhang H, et al. Microrna profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues. Onco Lett. 2021;22(2):595. https:\/\/doi.org\/10.3892\/ol.2021.12856.","journal-title":"Onco Lett"},{"key":"3283_CR26","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/ptr.7523","volume":"36","author":"L Chen","year":"2022","unstructured":"Chen L, Liu M, Yang H, Ren S, Sun Q, Zhao H, et al. Ursolic acid inhibits the activation of smoothened-independent non-canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade. Phytother Res. 2022;36:3555\u201370. https:\/\/doi.org\/10.1002\/ptr.7523.","journal-title":"Phytother Res"},{"key":"3283_CR27","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1021\/acs.jafc.2c06775","volume":"71","author":"H Zhao","year":"2023","unstructured":"Zhao H, Tang S, Tao Q, Ming T, Lei J, Liang Y, et al. Ursolic acid suppresses colorectal cancer by down-regulation of Wnt\/\u03b2-catenin signaling pathway activity. J Agric Food Chem. 2023;71:3981\u201393. https:\/\/doi.org\/10.1021\/acs.jafc.2c06775.","journal-title":"J Agric Food Chem"},{"issue":"14","key":"3283_CR28","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1002\/cam4.4536","volume":"11","author":"WL Ma","year":"2022","unstructured":"Ma WL, Chang N, Yu Y, Su YT, Chen GY, Cheng WC, et al. Ursolic acid silences CYP19A1\/aromatase to suppress gastric cancer growth. Cancer Med. 2022;11(14):2824\u201335. https:\/\/doi.org\/10.1002\/cam4.4536.","journal-title":"Cancer Med"},{"key":"3283_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/biomedicines9030297","volume":"9","author":"DY Kang","year":"2021","unstructured":"Kang DY, Sp N, Lee J-M, Jang K-J. Antitumor effects of ursolic acid through mediating the inhibition of STAT3\/PD-L1 signaling in non-small cell lung cancer cells. Biomedicines. 2021;9:297. https:\/\/doi.org\/10.3390\/biomedicines9030297.","journal-title":"Biomedicines"},{"key":"3283_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118854","volume":"265","author":"S Mandal","year":"2021","unstructured":"Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sci. 2021;265:118854. https:\/\/doi.org\/10.1016\/j.lfs.2020.118854.","journal-title":"Life Sci"},{"key":"3283_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","volume":"23","author":"X Yu","year":"2024","unstructured":"Yu X, Zhang Y, Luo F, Zhou Q, Zhu L. The role of micrornas in the gastric cancer tumor microenvironment. Mol Cancer. 2024;23:170. https:\/\/doi.org\/10.1186\/s12943-024-02084-x.","journal-title":"Mol Cancer"},{"key":"3283_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12935-020-01561-9","volume":"20","author":"X Guo","year":"2020","unstructured":"Guo X, Li M. LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p\/TET1 axis. Cancer Cell Int. 2020;20:507. https:\/\/doi.org\/10.1186\/s12935-020-01561-9.","journal-title":"Cancer Cell Int"},{"key":"3283_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104442","volume":"370","author":"C Liu","year":"2021","unstructured":"Liu C, Zhao Z, Guo S, Zhang L, Fan X, Zheng J. Exosomal miR-27a-3p derived from tumor-associated macrophage suppresses propranolol sensitivity in infantile hemangioma. Cell Immunol. 2021;370:104442. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104442.","journal-title":"Cell Immunol"},{"key":"3283_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12253-013-9689-y","volume":"20","author":"A Kawakita","year":"2014","unstructured":"Kawakita A, Yanamoto S, Yamada S-I, Naruse T, Takahashi H, Kawasaki G, et al. Microrna-21 promotes oral cancer invasion via the Wnt\/\u03b2-catenin pathway by targeting DKK2. Pathol Oncol Res. 2014;20:253\u201361. https:\/\/doi.org\/10.1007\/s12253-013-9689-y.","journal-title":"Pathol Oncol Res"},{"key":"3283_CR35","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.febslet.2013.04.002","volume":"587","author":"Q Li","year":"2013","unstructured":"Li Q, Shen K, Zhao Y, He X, Ma C, Wang L, et al. Microrna-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt\/\u03b2-catenin signaling pathway. FEBS Lett. 2013;587:1742\u20138. https:\/\/doi.org\/10.1016\/j.febslet.2013.04.002.","journal-title":"FEBS Lett"},{"key":"3283_CR36","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1093\/carcin\/bgs278","volume":"33","author":"J Zhu","year":"2012","unstructured":"Zhu J, Zhang S, Gu L, Di W. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma. Carcinogenesis. 2012;33:2334\u201343. https:\/\/doi.org\/10.1093\/carcin\/bgs278.","journal-title":"Carcinogenesis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03283-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03283-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:27:46Z","timestamp":1762295266000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03283-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03283-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies received approval from the Ethics Committee and the Animal Ethics Committee of Putuo Hospital, Shanghai University of Traditional Chinese Medicine (Ref. PTEC-A-2022\u201331-1 and DWEC-A-202211101) and were performed following established guidelines for laboratory animal care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1061"}}